Schering-Plough pulls EU antibiotic filing
LONDON, July 26 (Reuters) - U.S. drugmaker Schering-Plough Corp. (SGP.N: Quote, Profile, Research, Stock Buzz) has withdrawn its application to European regulators for experimental antibiotic garenoxacin, the European Medicines Agency said on Thursday.
The move follows a similar withdrawal in the United States last August. The drug was developed by Japan's Toyama Chemical (4518.T: Quote, Profile, Research, Stock Buzz), which was expected to get royalties on sales.
The European drugs watchdog said the withdrawal of garenoxacin followed a request for additional information, to which the company was unable to respond within the permitted timeframe.
© Thomson Reuters 2008 All rights reserved
Help us advance this story. Provide relevant links or share your insights using our comment box. Please be considerate and help us by reporting any abuse you find. Reuters will delete comments that don't meet community standards.
Have a correction to this article? Email the editors
Sphere
Piracy fight
Obama visits Jewish shrine